TherapeuticsMD, Inc. (TXMD) will hold its 2025 Annual Meeting virtually on December 15, 2025 (Record Date: October 20, 2025; 11.57M shares outstanding).
Critical Shareholder Proposal: The Board unanimously recommends approving a major amendment to increase authorized common stock from 32 million to 640 million shares. This action provides flexibility for future financing or M&A but carries a material risk of dilution for current shareholders. The Board also seeks approval for an annual (1 Year) advisory vote on executive compensation.
Governance and Compliance: All four director nomi
...